Company Filing History:
Years Active: 1976-1977
Title: Werner Haede: Innovator in Cardiac Therapy
Introduction
Werner Haede is a notable inventor based in Hofheim, Taunus, Germany. He has made significant contributions to the field of cardiac therapy through his innovative research and development of various compounds. With a total of 3 patents to his name, Haede's work focuses on improving treatments for cardiac insufficiency.
Latest Patents
Haede's latest patents include groundbreaking inventions such as "Heart glycosides and process for preparing them" and "Cyclic 2',3'-ethers of 3-hydroxy-14,15.beta.-oxido-14.beta.-bufa-4,20,22-trienolide, 3.beta.-(.alpha.-L-rhamnopyranoside) and process for preparing them." These compounds exhibit a strongly positive inotropic activity, making them valuable in the therapy of cardiac insufficiency. Another significant patent is "Digoxigenine-3-[2',3'-didesoxy-glycosides] and a process for their preparation." This invention involves a complex reaction process that results in products with cardiotonic, diuretic, and especially venotonic activity.
Career Highlights
Haede is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing cardiac therapies, showcasing his dedication to improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, Haede has collaborated with esteemed colleagues such as Ulrich Stache and Werner Fritsch. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Werner Haede's contributions to cardiac therapy through his innovative patents highlight his role as a significant inventor in the field. His work continues to impact the medical community positively, offering new hope for patients with cardiac insufficiency.